Coherus Biosciences | CHRS - 现金及等价物



金融业
股票价格
USD
资产
USD 258.34M
现金及等价物
USD 88.88M
销售成本
USD 4.05M
流动资产
USD 206.71M
流动负债
USD 140.39M
债务
USD 294.93M
股息收益率
0
EBIT
USD -39.08M
EBITDA
USD -43.33M
员工
306
EPS每股收益
USD -0.43
股本和储备
USD 61.01M
销售毛利
USD 8.7M
债务利息支出
USD 2.25M
贷款资金
USD 51.08M
市值
USD 191.1M
净收入
USD -37.64M
营业费用
USD 51.83M
营业利润
USD -39.08M
普通股股本
USD 121.16M
税前利润
USD -46.35M
销售收入
USD 12.75M
销售和管理费用
USD 15M
股票
USD 3.17M
贸易债权人
USD 9.92M
应收帐款人
USD 18.42M


现金及等价物 更改 日
AbbVie USD 5.23B 400M 2025-12
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Akebia Therapeutics USD 184.84M 18.4M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.97B 240M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Fujifilm JPY 160.88B 906M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Merck USD 18.17B 10.16B 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 984.65M 312.03M 2025-12
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Xencor USD 54.07M 25.78M 2025-12
Zoetis USD 2.08B 649M 2025-09